Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 ‘CaboGIST’
-
Published:2020-07
Issue:
Volume:134
Page:62-74
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Schöffski Patrick,
Mir Olivier,
Kasper Bernd,
Papai Zsuzsanna,
Blay Jean-Yves,
Italiano Antoine,
Benson Charlotte,
Kopeckova Katerina,
Ali NasimORCID,
Dileo Palma,
LeCesne Axel,
Menge Franka,
Cousin Sophie,
Wardelmann Eva,
Wozniak Agnieszka,
Marreaud Sandrine,
Litiere Saskia,
Zaffaroni FacundoORCID,
Nzokirantevye Axelle,
Vanden Bempt Isabelle,
Gelderblom Hans
Funder
EORTC
Stichting tegen Kanker
Exelixis
Subject
Cancer Research,Oncology
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献